Ignite Proteomics - Crunchbase Company Profile & Funding

Overview

Ignite Proteomics

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Ignite Proteomics

CB Rank

150513

Ignite Proteomics is a biotechnology company that offers novel proteomic assays.

Acquired by

Aditxt Therapeutics

Founded

obfuscation

Private

11-50

igniteproteomics.com

Analytics

Biotechnology

Medical

Key People

Jeffrey Busch: Chief Executive Officer
Past Role: Chiron Real Estate, Chief Executive Officer

Details

Legal Name

Ignite Proteomics

Operating Status

Active

Company Type

For Profit

Contact Email

investors@igniteproteomics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Ignite Proteomics Oncology Registry

A prospective oncology registry enrolling up to 10,000 patients to pair RPPA-based functional proteomics with therapy selection and outcomes tracking.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

M&A Details

Ignite Proteomics

was acquired by

Aditxt Therapeutics

for

obfuscation

. This deal was done in

Stock

Transaction Name

Ignite Proteomics acquired by Aditxt Therapeutics

Acquired by

Aditxt Therapeutics

Announced Date

obfuscation

Price

obfuscation

Market Intelligence

People

View Profiles & Contacts

Headcount

11-50

Employee Profiles

Jeffrey Busch Chief Executive Officer

News

News and Press

News•

Jun 9, 2026

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Jun 9, 2026

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Jun 9, 2026

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Jun 8, 2026

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

Access a complete feed of recent news and press, from product launches to leadership changes.

Technology

View Tech Report

Monthly Web Visits

184

Active Website Tech Count

Ignite Proteomics

is actively using

technologies for its website, according to BuiltWith. These include

Euro

and

Comcast

Lists Featuring This Company

Biotechnology Companies With Fewer Than 50 Employees (Top 10K)

9,938 Number of Organizations • $252.3B Total Funding Amount • 39,349 Number of Investors

Biotechnology Companies With More Than 10 Employees (Top 10K)

9,897 Number of Organizations • $1.3T Total Funding Amount • 48,985 Number of Investors

Analytics Acquired Companies With More Than 10 Employees

1,890 Number of Organizations • $60.5B Total Funding Amount • 5,739 Number of Investors

Analytics Acquired Companies With Fewer Than 1000 Employees

2,157 Number of Organizations • $31.9B Total Funding Amount • 5,967 Number of Investors

Sub-Organizations

Frequently Asked Questions

Who are

Ignite Proteomics

's competitors? Alternatives and possible competitors to

may include

, and